BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 28, 2008
View Archived Issues
FDA Pledges Renewed Focus to Boost Post-Market Safety
More than 100 years after the creation of the FDA, the agency said it now will apply the same standards it uses in its premarket drug reviews to manage its post-marketing safety process. (BioWorld Today)
Read More
Regeneron Gets FDA's OK for Arcalyst in CAPS
Read More
New Connections of Clotting to Inflammation in Sepsis, MS
Read More
NewCo News: Profectus Seeks a Bio Niche Hitting HIV from all Angles
Read More
Biogen, Elan Nicked on Reports of Tysabri-Linked Liver Injuries
Read More
RegeneRx Secures $5M for Wound Healing Trials
Read More
Receptor Logic Finds Partner to Develop T-Cell Mimics
Read More
Other News To Note
Read More
Earnings Roundup
Read More
Clinic Roundup
Read More
